共 47 条
[1]
Kleijnen J(1992)Ginkgo biloba for cerebral insufficiency Br J Clin Pharmacol. 34 352-8
[2]
Knipschild P(2002)Pharmaco-economic evaluation of Ginkgo special extract EGb 761® for dementias in Austria Wien Med Wochenschr. 152 427-31
[3]
Hörr R(2004)Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761® Wien Med Wochenschr. 154 511-4
[4]
Kieser M(2007)Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial Arzneimittelforschung. 57 4-11
[5]
Haan J(2011)Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomized controlled trial Int J Geriatr Psychiatry. 26 1186-94
[6]
Hörr R(2012)Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomized, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg J Psychiatr Res. 46 713-23
[7]
Napryeyenko O(1994)Factors affecting course and survival in Alzheimer’s disease. A 9-year longitudinal study Arch Neurol. 51 1213-9
[8]
Borzenko I(1996)The consortium to establish a registry for Alzheimer’s disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer’s disease Neurology. 46 656-60
[9]
Ihl R(1999)The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease Arch Neurol. 56 1388-93
[10]
Bachinskaya N(1997)Validity and reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer’s Disease Cooperative Study Alzheimer Dis Assoc Disord. 11 S22-300